Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
- Hossein Borghaei
- , Katherine Alpaugh
- , Gunnar Hedlund
- , Göran Forsberg
- , Corey Langer
- , Andre Rogatko
- , Robert Hawkins
- , Svein Dueland
- , Ulrik Lassen
- , Roger B. Cohen
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations